Equities researchers at William Blair issued their FY2028 earnings estimates for Tempest Therapeutics in a research report ...

Stock analysts at William Blair issued their Q2 2025 earnings estimates for StoneX Group in a research report issued on Wednesday, March 26th. William Blair analyst J. Schmitt forecasts that the ...

In a report released today, Andy Hsieh from William Blair maintained a Hold rating on FibroGen (FGEN – Research Report). The company’s shares ...

CBOE), following the company's latest earnings report. CBOE Holdings reported an adjusted EPS of $2.10, falling short of both William Blair's estimate of $2.12 and the consensus estimate of $2.13.

On Tuesday, William Blair reaffirmed their positive stance ... as InvestingPro data shows four analysts have recently revised their earnings estimates upward for the upcoming period.

Valmont downgraded at William Blair, which cites potential for significant downward guidance revision due to near-term ...

The firm believes the company’s valuation remains attractive, with DocuSign trading at 16.9x the firm’s calendar 2026 free cash flow estimate. William Blair sees room for margin expansion in ...

In a report released today, Louie DiPalma from William Blair maintained a Buy rating on AAR (AIR – Research Report). The company’s shares ...

On Friday, William Blair analysts remained bullish on AAON Inc (NASDAQ:AAON), maintaining their Outperform rating despite lowering their first-half 2025 earnings estimates. The revision reflects ...